Bixiye
Zeposia (ozanimod) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Natiijooyinka Raadinta
Soo bandhiga 4061 - 4070 ee natiijooyinka 4132
Bixiye
Triptans - Commercial
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Bixiye
Topical Corticosteroids - Commercial
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Bixiye
Urea Cycle Disorders - Commercial
Oggolaanshaha Hore
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Bixiye
Topical NSAID - Commercial
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Bixiye
Topical Actinic Keratosis, Basal Cell Carcinoma, Genital Wart Agents - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Bixiye
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors and Combinations - Commercial
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Bixiye
Corticotropin - Commercial
Oggolaanshaha Hore
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Bixiye
Biologic Immunomodulators - FocusRx (For Pharmacy Benefits Only) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Bixiye
Saxenda Wegovy Zepbound - Commercial
Coverage Exception, Formulary Exception, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026